Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$2.07B
Total Bought:
$494.14M
Total Sold:
$203.41M
Net Transaction:
+$290.72M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)8,118,8928,118,8920$306.41M$647.32M31.23%+$340.91M
Revolution Medicines, Inc.(RVMD)1,652,8081,961,795+308,987$160.74M$367.40M17.73%+$206.67M
ABIVAX Société AnonymeADS(ABVX)1,461,9241,557,924+96,000$162.79M$207.61M10.02%+$44.82M
Vaxcyte, Inc.(PCVX)2,060,7192,188,636+127,917$119.75M$127.23M6.14%+$7.48M
Exelixis, Inc.(EXEL)1,553,2621,553,2620$66.62M$84.51M4.08%+$17.89M
Tango Therapeutics, Inc.(TNGX)2,408,7982,500,103+91,305$50.39M$78.15M3.77%+$27.76M
Avalo Therapeutics, Inc.(AVTX)1,635,0233,163,866+1,528,843$24.41M$58.47M2.82%+$34.06M
Xenon Pharmaceuticals Inc.(XENE)1,393,027889,944-503,083$81.00M$53.72M2.59%-$27.29M
Adma Biologics Inc4,756,5115,725,007+968,496$42.86M$47.92M2.31%+$5.06M
LB Pharmaceuticals Inc(LBRX)1,438,0701,438,0700$34.63M$46.67M2.25%+$12.04M
Immunocore Holdings plcADS(IMCR)01,381,317+1,381,317$0$43.86M2.12%+$43.86M
Viridian Therapeutics, Inc.(VRDN)02,193,981+2,193,981$0$40.30M1.94%+$40.30M
Vor Biopharma Inc.(VOR)1,925,0661,925,0660$34.34M$35.44M1.71%+$1.10M
SAB Biotherapeutics, Inc.(SABS)7,967,2077,967,2070$30.51M$31.07M1.50%+$557.7K
Inventiva S.A.ADS(IVA)4,974,9068,163,191+3,188,285$27.61M$30.86M1.49%+$3.25M
Aura Biosciences, Inc.(AURA)229,8644,298,248+4,068,384$1.54M$30.52M1.47%+$28.98M
Tyra Biosciences, Inc.(TYRA)1,276,968806,986-469,982$48.91M$25.78M1.24%-$23.13M
Opus Genetics, Inc.(IRD)6,075,0286,077,084+2,056$27.64M$24.98M1.21%-$2.66M
Anika Therapeutics Inc1,435,1301,435,1300$20.81M$21.00M1.01%+$186.6K
Sagimet Biosciences Inc.COM SER A(SGMT)02,500,000+2,500,000$0$19.32M0.93%+$19.32M
Artiva Biotherapeutics, Inc.(ARTV)01,736,111+1,736,111$0$16.84M0.81%+$16.84M
Faeth Therapeutics, Inc.(FTH)126,002629,467+503,465$3.97M$15.74M0.76%+$11.77M
MBX Biosciences, Inc.(MBX)848,590200,000-648,590$25.33M$11.04M0.53%-$14.29M
Verrica Pharmaceuticals Inc.(VRCA)923,910923,9100$4.89M$5.65M0.27%+$766.8K
Cellectar Biosciences, Inc.(CLRB)0469,998+469,998$0$1.31M0.06%+$1.31M
Maze Therapeutics, Inc.(MAZE)614,9620-614,962$18.36M$0—-$18.36M
Mineralys Therapeutics, Inc.(MLYS)2,772,6540-2,772,654$75.11M$0—-$75.11M
Spyre Therapeutics, Inc.(SYRE)878,1270-878,127$44.29M$0—-$44.29M
Xilio Therapeutics, Inc.(XLO)112,1280-112,128$943.0K$0—-$943.0K
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q2 2026 | TickerTrail